What is ANI Pharmaceuticals's work in process?

ANI Pharmaceuticals (ANIP) reported work in process of $5.29M in Q1 2026.

How has ANI Pharmaceuticals's work in process changed year-over-year?

ANI Pharmaceuticals's work in process decreased by 3.5% year-over-year, from $5.48M to $5.29M.

What is the long-term trend for ANI Pharmaceuticals's work in process?

Over 3 years (2022 to 2025), ANI Pharmaceuticals's work in process has grown at a 16.3% compound annual growth rate (CAGR), from $1.89M to $2.97M.

What does work in process mean?

Partially completed goods currently in the manufacturing process, including materials, labor, and overhead costs incurred to date.

ANI Pharmaceuticals ANIP Work in process

Work in process at other companies

ALN

Alnylam PharmaceuticalsALNY

$65.46M+21.2%

Aurinia PharmaceuticalsAUPH

$41.42M-0.8%

OrganonOGN

$800M+16.3%

Mirum Pharmaceuticals, Inc.MIRM

$19.49M+23.2%

ViatrisVTRS

——

AmgenAMGN

——

Other financials

Income statement

See full

Revenue$237.5M+20.5%

Gross profit$143.9M+16.0%

Operating income$38.9M+48.5%

Net income$29.5M+88.1%

EPS (diluted)$1.28+85.5%

Balance sheet

See full

Cash & equivalents$311.2M+108%

Total debt$305.3M-3.5%

Total equity$562.3M+34.3%

Total assets$1.4B+10.0%

Cash flow

See full

Operating cash flow$58.4M+66.8%

CapEx$6.1M+146%

Free cash flow$52.3M+60.8%

Valuation

See full

Market cap$1.89B+18.3%

Enterprise value$1.88B+5.8%

P/E20.5×—

P/S2×-0.3×

Profitability

See full

Gross margin60.8%+1.5pp

Operating margin13.4%—

Net margin10%+8.1pp

FCF margin20.7%+10.8pp

Returns & leverage

See full

Return on equity18.8%+15.6pp

Debt / equity0.5×-0.2×

Current ratio3.1×+0.5×

Where this comes from

Reported directly by ANI Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:InventoryWorkInProcess.

The official record: ANI Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about ANI Pharmaceuticals's work in process.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is ANI Pharmaceuticals's work in process?: ANI Pharmaceuticals (ANIP) reported work in process of $5.29M in Q1 2026.
How has ANI Pharmaceuticals's work in process changed year-over-year?: ANI Pharmaceuticals's work in process decreased by 3.5% year-over-year, from $5.48M to $5.29M.
What is the long-term trend for ANI Pharmaceuticals's work in process?: Over 3 years (2022 to 2025), ANI Pharmaceuticals's work in process has grown at a 16.3% compound annual growth rate (CAGR), from $1.89M to $2.97M.
What does work in process mean?: Partially completed goods currently in the manufacturing process, including materials, labor, and overhead costs incurred to date.